Donor hemovigilance: a call to arms

Affiliations

¹ Division of Blood Components and Devices, Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.

Editorial

Emily K Storch. Transfusion. 2020 Jun.

. 2020 Jun;60(6):1115-1117.

doi: 10.1111/trf.15854.

¹ Division of Blood Components and Devices, Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.

No abstract available

References

1. de Vries RR, Faber JC, Strengers PF, et al. Haemovigilance: an effective tool for improving transfusion practice. Vox Sang 2011;100:60-7.
1. Jorgensen J, Sorensen, BS. Donor vigilance. ISBT Sci Ser 2008;3:48-53.
1. Wiersum-Osselton JC, Marijt-van der Kreek T, de Kort WL. Donor vigilance: what are we doing about it? Biologicals 2012;40:176-9.
1. International Haemovigilance Network: Definition of Haemovigilance. [cited April 25, 2020]. Available from: https://www.ihn-org.com/about/haemovigilance/
1. Eder AF. Improving safety for young blood donors. Transfus Med Rev 2012;26:14-26.